Skip to main content
. Author manuscript; available in PMC: 2010 Jun 4.
Published in final edited form as: Acta Neuropathol. 2010 Mar 16;119(6):669–678. doi: 10.1007/s00401-010-0667-0

Fig. 2.

Fig. 2

AD biomarkers identified by each of the three analytical strategies (logistic regression, random forest, and PAM). a Biomarkers useful in distinguishing between subjects with AD and normal cognition. b Biomarkers useful in distinguishing between subjects with AD and other non-AD neurodegenerative disorders. Analytes in overlapping regions were identified by multiple strategies as important biomarkers